Results 41 to 50 of about 10,382 (171)

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

The Future of Transcatheter Therapy for Mitral Valve Disease

Cardiovascular Innovations and Applications, 2016
The develop percutaneous treatments for mitral regurgitation (MR) have been based on established surgical procedures. Most are based in some way on mitral annuloplasty.
Ted Feldman, Mayra Guerrero
doaj   +1 more source

Minimally invasive treatment of mitral valve disease with severe mitral annular calcificationCentral MessagePerspective

JTCVS Techniques, 2023
Objective: Mitral valve disease in presence of severe mitral annular calcification (MAC) remains a challenge for surgeons to address. Conventional surgical techniques have potential for heightened morbidity and mortality.
Andrew D. Wisneski, MD, Barbara Hamilton, MD, Tom C. Nguyen, MD   +2 more
doaj   +1 more source

Circulating Musclin is associated with skeletal muscle function and subclinical cardiac dysfunction in patients with cancer

British Journal of Pharmacology, EarlyView.
Background and Purpose Musclin (osteocrin) is a skeletal muscle‐derived peptide that has been implicated in cardioprotective signalling pathways. Its relevance in cancer patients, who frequently experience muscle wasting and cardiotoxicity, remains unclear. This study aimed to determine whether circulating Musclin levels reflect functional capacity and
Jannek Brauer, Daniel Finke, Sebastian Romann, Norbert Frey, Joerg Heineke, Lorenz H. Lehmann   +5 more
wiley   +1 more source

PFA Under Deep Sedation and Non‐Invasive Monitoring in Atrial Fibrillation Patients With Obstructive Sleep Apnea

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Clinical data about pulsed field ablation (PFA) under deep sedation among patients with obstructive sleep apnea (OSA) are limited, while the optimal periprocedural monitoring is not established. We report our experience in PFA among patients with atrial fibrillation (AF) and OSA, using a continuous non‐invasive respiratory and ...
Dionyssios Leftheriotis, Konstantinos A. Papathanasiou, Efstratios Karamanolis, Areti Vlachodiamanti, Evangelia Stamatopoulou, Maria Polikandrioti, Panagiota Flevari   +6 more
wiley   +1 more source

Adjunctive Techniques for Repair of Ischaemic Mitral Regurgitation

Cardiac Failure Review, 2021
Ischaemic mitral regurgitation is a complex process with debate in the literature as to the optimal treatment pathway. Multiple therapies are available to alleviate mitral regurgitation including medical management, transcatheter edge-to-edge repair ...
Sigrid L Johannesen, Colin M Barker, Melissa M Levack   +2 more
doaj   +1 more source

Leadless Pacemaker Implantation in High‐Risk Patients: Real‐World Outcomes From a Multicenter Israeli Registry

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz, Marianna Vander, David Luria, Moshe Rav Acha, Yoav Michowitz, Alon Barsheshet, Gregory Golovchiner, Roy Beinart   +7 more
wiley   +1 more source

When surgery is not an option: case report of transcatheter valve-in-valve replacement for mitral valve dysfunction

The Egyptian Heart Journal
Background Heart valve diseases affect over 100 million people globally, with mitral regurgitation being the most common in developed countries. Bioprosthetic heart valves, frequently used for replacement, typically last 10–15 years before degeneration ...
Yakup Alsancak, Hasan Kan, Ahmet Seyfettin Gürbüz, Nergiz Aydın, Muhammed Fatih Kaleli   +4 more
doaj   +1 more source

Racial Disparities in the Utilization and Outcomes of Structural Heart Disease Interventions in the United States

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Data on race‐ and ethnicity‐based disparities in the utilization and outcomes of structural heart disease interventions in the United States are scarce.
Mohamad Alkhouli, Fahad Alqahtani, David R. Holmes, Chalak Berzingi   +3 more
doaj   +1 more source

Simultaneous Transcatheter Mitral and Tricuspid Valve-in-Valve Replacement [PDF]

The Annals of Thoracic Surgery, 2019
After the popularization of transcatheter aortic valve-in-valve replacement, mitral valve-in-valve is being increasingly performed for failing bioprostheses or annuloplasty rings. In the tricuspid position, despite smaller experience, valve-in-valve is also becoming an alternative to high-risk redo tricuspid surgery.
Guillermo, Ventosa-Fernandez, Laura, Vidal, Ruben, Tarrio, Alfredo, Gomez, Vicente, Peral, Jose Ignacio, Saez de Ibarra   +5 more
openaire   +2 more sources